{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:59:58Z","timestamp":1760425198886},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00213-013-3199-1","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T04:11:37Z","timestamp":1372911097000},"page":"23-27","source":"Crossref","is-referenced-by-count":13,"title":["The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients"],"prefix":"10.1007","volume":"230","author":[{"given":"Avi","family":"Amrami-Weizman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Maayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Gil-Ad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artashez","family":"Pashinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camil","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Poyurovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"3199_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2007.03.029","volume":"93","author":"T Baptista","year":"2007","unstructured":"Baptista T, Rangel N, Fern\u00e1ndez V, Carrizo E, El Fakih Y, Uzc\u00e1tegui E, Galeazzi T, Guti\u00e9rrez MA, Servigna M, D\u00e1vila A, Uzc\u00e1tegui M, Serrano A, Connell L, Beaulieu S, de Baptista EA (2007) Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial. Schizophr Res 93:99\u2013108","journal-title":"Schizophr Res"},{"key":"3199_CR2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/11589060-000000000-00000","volume":"31","author":"L Citrome","year":"2011","unstructured":"Citrome L, Holt RI, Walker DJ, Hoffmann VP (2011) Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder. Clin Drug Investig 31:455\u2013482","journal-title":"Clin Drug Investig"},{"key":"3199_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2005-871738","volume":"5","author":"RV Considine","year":"2005","unstructured":"Considine RV (2005) Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. Semin Vasc Med 5:15\u201324","journal-title":"Semin Vasc Med"},{"issue":"1","key":"3199_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","volume":"221","author":"KJ Davey","year":"2012","unstructured":"Davey KJ, O'Mahony SM, Schellekens H, O'Sullivan O, Bienenstock J, Cotter PD, Dinan TG, Cryan JF (2012) Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl) 221(1):155\u2013169","journal-title":"Psychopharmacology (Berl)"},{"key":"3199_CR5","doi-asserted-by":"crossref","unstructured":"Hu S, Yao M, Peterson BS, Xu D, Hu J, Tang J, Fan B, Liao Z, Yuan T, Li Y, Yue W, Wei N, Zhou W, Huang M, Xu Y. (2013) A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and \u03b2-cell function in schizophrenic patients. Psychopharmacology (Berl). doi: 10.1007\/s00213-013-3073-1","DOI":"10.1007\/s00213-013-3073-1"},{"key":"3199_CR6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2265.2011.04073.x","volume":"75","author":"CM Jankowski","year":"2010","unstructured":"Jankowski CM, Gozansky WS, Van Pelt RE, Wolfe P, Schwartz RS, Kohrt WM (2010) Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids. Clin Endocrinol (Oxf) 75:456\u2013463","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3199_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","volume":"219","author":"G Jassim","year":"2012","unstructured":"Jassim G, Skrede S, V\u00e1zquez MJ, Wergedal H, Vik-Mo AO, Lunder N, Di\u00e9guez C, Vidal-Puig A, Berge RK, L\u00f3pez M, Steen VM, Fern\u00f8 J (2012) Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl) 219:783\u2013794","journal-title":"Psychopharmacology (Berl)"},{"key":"3199_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/heartjnl-2012-302689","volume":"99","author":"T Kasai","year":"2013","unstructured":"Kasai T, Miyauchi K, Yanagisawa N, Kajimoto K, Kubota N, Ogita M, Tsuboi S, Amano A, Daida H (2013) Mortality risk of triglyceride levels in patients with coronary artery disease. Heart 99:22\u201329","journal-title":"Heart"},{"key":"3199_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yfrne.2008.11.002","volume":"30","author":"N Maninger","year":"2009","unstructured":"Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30:65\u201391","journal-title":"Front Neuroendocrinol"},{"key":"3199_CR10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-012-2850-6","volume":"225","author":"JJ Ou","year":"2013","unstructured":"Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J, Guo XF, Wu RR, Zhao JP (2013) Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Psychopharmacology (Berl) 225:627\u2013635","journal-title":"Psychopharmacology (Berl)"},{"key":"3199_CR11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-007-0731-1","volume":"192","author":"M Poyurovsky","year":"2007","unstructured":"Poyurovsky M, Fuchs C, Pashinian A, Levi A, Faragian S, Maayan R, Gil-Ad I (2007) Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. Psychopharmacology (Berl) 192:441\u2013448","journal-title":"Psychopharmacology (Berl)"},{"key":"3199_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/appi.ajp.160.2.297","volume":"160","author":"M Poyurovsky","year":"2003","unstructured":"Poyurovsky M, Isaacs I, Fuchs C, Schneidman M, Faragian S, Weizman R, Weizman A (2003) Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Am J Psychiatry 160:297\u2013302","journal-title":"Am J Psychiatry"},{"key":"3199_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0031-9384(99)00185-7","volume":"68","author":"A Prasad","year":"2000","unstructured":"Prasad A, Richards RJ, Svec F, Porter JR, Prasad C (2000) Dehydroepiandrosterone-mediated decrease in caloric intake by obese Zucker rats is not due to changes in serum entrostatin-like immunoreactivity. Physiol Behav 68:341\u2013345","journal-title":"Physiol Behav"},{"key":"3199_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpsychires.2009.07.002","volume":"44","author":"MS Ritsner","year":"2010","unstructured":"Ritsner MS, Strous RD (2010) Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA. J Psychiatr Res 44:75\u201380","journal-title":"J Psychiatr Res"},{"key":"3199_CR15","first-page":"2583","volume":"118","author":"M Rosenbaum","year":"2008","unstructured":"Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J (2008) Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest 118:2583\u20132591","journal-title":"J Clin Invest"},{"key":"3199_CR16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jnutbio.2007.10.005","volume":"19","author":"J S\u00e1nchez","year":"2008","unstructured":"S\u00e1nchez J, P\u00e9rez-Heredia F, Priego T, Portillo MP, Zamora S, Garaulet M, Palou A (2008) Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity. J Nutr Biochem 19:809\u2013818","journal-title":"J Nutr Biochem"},{"key":"3199_CR17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","volume":"115","author":"N Sarwar","year":"2007","unstructured":"Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V (2007) Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115:450\u2013458","journal-title":"Circulation"},{"key":"3199_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2826.2006.01516.x","volume":"19","author":"C Sch\u00fcle","year":"2007","unstructured":"Sch\u00fcle C (2007) Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol 19:213\u2013226","journal-title":"J Neuroendocrinol"},{"key":"3199_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0306-4530(03)00022-2","volume":"29","author":"C Sch\u00fcle","year":"2004","unstructured":"Sch\u00fcle C, Baghai T, Schmidbauer S, Bidlingmaier M, Strasburger CJ, Laakmann G (2004) Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology 29:185\u2013200","journal-title":"Psychoneuroendocrinology"},{"key":"3199_CR20","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1007\/BF03327498","volume":"10","author":"RO Silveira","year":"2005","unstructured":"Silveira RO, Zanatto V, Appolin\u00e1rio JC, Kapczinski F (2005) An open trial of reboxetine in obese patients with binge eating disorder. Eat Weight Disord 10:e93\u2013e96","journal-title":"Eat Weight Disord"},{"key":"3199_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.60.2.133","volume":"60","author":"RD Strous","year":"2003","unstructured":"Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A (2003) Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60:133\u2013141","journal-title":"Arch Gen Psychiatry"},{"key":"3199_CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psyneuen.2006.11.002","volume":"32","author":"RD Strous","year":"2007","unstructured":"Strous RD, Stryjer R, Maayan R, Gal G, Viglin D, Katz E, Eisner D, Weizman A (2007) Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. Psychoneuroendocrinology 32:96\u2013105","journal-title":"Psychoneuroendocrinology"},{"key":"3199_CR23","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487\u20131495","journal-title":"Diabetes Care"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3199-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3199-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:36:28Z","timestamp":1558614988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["3199"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3199-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}